Literature DB >> 12454810

Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.

Kaori Kumazaki1, Masahiro Nakayama, Noriyuki Suehara, Yoshinao Wada.   

Abstract

The vascular endothelial growth factor (VEGF) family and its receptors have multifunctional activities besides angiogenesis, and some of these molecules are induced by hypoxia/ischemia. They are known to be expressed in human placenta, but little is known about their involvement in pathologic conditions. We have investigated the expression patterns of VEGF, placental growth factor (PlGF), and their receptors fms-like tyrosine kinase (Flt-1) and kinase insert domain-containing region (KDR) in placentas with histopathological changes. Forty-two placentas from normal and complicated pregnancies delivered in the second and third trimesters were fixed with paraformaldehyde and embedded in paraffin. In situ hybridization and immunohistochemistry were performed on serial sections. In the villi with characteristic hypoxic/ischemic changes (HIC), including increased syncytial knots, infarction, or hypercapillarization, intense immunostaining for VEGF was detected in the media of blood vessels, and increased staining for KDR was demonstrated in the endothelial cells. Strong PlGF immunoreactivity was localized to the degenerative trophoblasts around the infarctions. Marked Flt-1 mRNA expression in the syncytiotrophoblast layers of HIC villi was identified, but some samples did not show ligand expression in these regions. Positive immunostaining for VEGF, PlGF, and Flt-1 was observed in infiltrated neutrophils and macrophages in the placentas with chorioamnionitis (CAM). These findings suggested that in the hypoxic/ischemic regions, VEGF and KDR expression is increased within the villous vessels by paracrine regulation, whereas the expression of PlGF and Flt-1 is enhanced in villous trophoblasts by autocrine regulation. The Flt-1 gene may also be up-regulated directly by hypoxia/ischemia independently of ligand mediation. Furthermore, the results indicated that VEGF and PlGF stimulate inflammatory cell migration by autocrine regulation via the Flt-1 receptor in the CAM placenta. Thus, various functions of VEGF family members participate in the development of pathologic changes in the placenta. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454810     DOI: 10.1053/hupa.2002.129420

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  30 in total

1.  Preeclampsia does not alter vascular growth and expression of CD31 and vascular endothelial cadherin in human placentas.

Authors:  Yan Li; Ying-Jie Zhao; Qing-Yun Zou; Kevin Zhang; Yan-Ming Wu; Chi Zhou; Kai Wang; Jing Zheng
Journal:  J Histochem Cytochem       Date:  2014-10-31       Impact factor: 2.479

2.  Unexplained fetal death: another anti-angiogenic state.

Authors:  Jimmy Espinoza; Tinnakorn Chaiworapongsa; Roberto Romero; Yeon Mee Kim; Gi Jin Kim; Jyh Kae Nien; Juan Pedro Kusanovic; Offer Erez; Emmanuel Bujold; Luis F Gonçalves; Ricardo Gomez; Samuel Edwin
Journal:  J Matern Fetal Neonatal Med       Date:  2007-07

3.  Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes.

Authors:  Zeynep Alpay Savasan; Roberto Romero; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Sun Kwon Kim; Shali Mazaki-Tovi; Edi Vaisbuch; Pooja Mittal; Giovanna Ogge; Ichchha Madan; Zhong Dong; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

4.  Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.

Authors:  C Li; N S Raikwar; M K Santillan; D A Santillan; C P Thomas
Journal:  Placenta       Date:  2015-01-17       Impact factor: 3.481

Review 5.  Angiogenic factors in preeclampsia and related disorders.

Authors:  Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

6.  Maternal protein restriction alters VEGF signaling and decreases pulmonary alveolar in fetal rats.

Authors:  Xiaomei Liu; Yan Lin; Baoling Tian; Jianing Miao; Chunyan Xi; Caixia Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

7.  Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

Authors:  Eleazar Soto; Roberto Romero; Juan Pedro Kusanovic; Giovanna Ogge; Youssef Hussein; Lami Yeo; Sonia S Hassan; Chong Jai Kim; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-25

8.  Discordant placental echogenicity: a novel sign of impaired placental perfusion in twin-twin transfusion syndrome?

Authors:  Juan Pedro Kusanovic; Roberto Romero; Francesca Gotsch; Pooja Mittal; Offer Erez; Chong Jai Kim; Sonia S Hassan; Jimmy Espinoza; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2010-01

9.  Placental hypoxia during placental malaria.

Authors:  Philippe Boeuf; Aimee Tan; Cleofe Romagosa; Jane Radford; Victor Mwapasa; Malcolm E Molyneux; Steven R Meshnick; Nicholas H Hunt; Stephen J Rogerson
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

10.  Comparison of Efficiency and Function of Vascular Endothelial Growth Factor Adenovirus Vectors in Endothelial Cells for Gene Therapy of Placental Insufficiency.

Authors:  Carlo Rossi; Mark Lees; Vedanta Mehta; Tommi Heikura; John Martin; Ian Zachary; Rebecca Spencer; Donald M Peebles; Robert Shaw; Minna Karhinen; Seppo Yla-Herttuala; Anna L David
Journal:  Hum Gene Ther       Date:  2020-11       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.